Whitehawk Therapeutics (WHWK) Revenue (2018 - 2025)

Whitehawk Therapeutics (WHWK) has 7 years of Revenue data on file, last reported at $7.1 million in Q1 2025.

• Quarterly Revenue rose 33.48% year-over-year to $7.1 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $7.1 million (down 72.5% YoY) and the FY2025 annual result came in at $7.1 million, down 72.5% from the prior year.
• Revenue slipped to $7.1 million in Q1 2025 per WHWK's latest filing, from $7.2 million in the prior quarter.
• Across five years, Revenue topped out at $14.0 million in Q4 2021 and bottomed at $120000.0 in Q1 2021.
• The 5-year median for Revenue is $6.0 million (2023), against an average of $5.8 million.
• Peak annual rise in Revenue reached 1822.5% in 2022, while the deepest fall reached 62.66% in 2022.
• Tracing WHWK's Revenue over 5 years: stood at $14.0 million in 2021, then slumped by 62.66% to $5.2 million in 2022, then climbed by 21.03% to $6.3 million in 2023, then increased by 14.43% to $7.2 million in 2024, then fell by 1.3% to $7.1 million in 2025.
• Per Business Quant, the three latest WHWK Revenue figures stand at $7.1 million (Q1 2025), $7.2 million (Q4 2024), and $7.2 million (Q3 2024).

Peer Comparison